Skip to content

Injectable Platelet Rich Fibrin With Collagen Matrix in Treatment of Multiple Gingival Recession.

The Value of Injectable Platelet Rich Fibrin With Volume Stable Collagen Matrix in Treatment of Multiple Gingival Recession; a Randomized Clinical Trial.

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05389059
Enrollment
20
Registered
2022-05-24
Start date
2022-04-25
Completion date
2023-09-01
Last updated
2022-05-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gingival Diseases, Traumatic Injury

Keywords

Gingival Recession, Collagen Matrix, Plasma rich proten

Brief summary

This study is proposing the use of i-PRF clot as a scaffold for the XCM in order to obtain a novel biomaterial, incorporating active growth factors and collagen matrix in a single framework, based on the potential effect of i-PRF to enhance fibroblast activity and angiogenesis stimulation for treatment of multiple gingival recession.

Interventions

PROCEDURECAF+CM

Periodontal surgery including CAF+CM application

PROCEDUREI-PRF

Periodontal surgery including CAF+CM application with i-PRF

Sponsors

University of Baghdad
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* Presence of at least two localized gingival recessions on either sides of the maxilla and/or mandible excluding molar region. * The cemento-enamel junction (CEJ) is visible in the teeth for root coverage procedures. * All recessions are type 1recession RT1 (cairo et al,2011) which correspond to Miller I&II gingival recession * All patients must demonstrate adequate plaque control with a fullmouth plaque score less than 20% and with . * All patients at least 18 years of age and of both genders.

Exclusion criteria

* Smoker Patients . * Patients with diabetes. * Patients with a history of malignancy, radiotherapy, or chemotherapy for malignancy. * pregnant or nursing women. * Patients taking medications or having treatments with an effect on mucosal healing in general (e.g. steroids, large doses of antiinflammatory drugs). * Patients with a disease affecting connective tissue metabolism. * Patients allergic to collagen.

Design outcomes

Primary

MeasureTime frameDescription
Reduction in gingival recession depth on the buccal sides of type one gingival recessionRT1Between the baseline preoperative measurement and follow-up at 3 months and 6 monthsThe primary outcome of the study is the reduction in gingival recession depth on the buccal sides of RT1 gingival recession, between the baseline preoperative measurement and follow-up at 3 months and 6 months. The Recession Depth (RD) is Measured in millimeter (mm) from CEJ (Cemento-Enamel-Junction) to the gingival margin using UNC-15 probe.

Secondary

MeasureTime frameDescription
Measuring Bleeding On Probing (BOP)Between the baseline preoperative measurement and follow-up at 3 months and 6 monthsBleeding On Probing (BOP) is measured as a percentage of sites with bleeding on probing using a manual periodontal probe.
Improvement in Gingival Thickness (GT)Between the baseline preoperative measurement and follow-up at 3 months and 6 monthsGingival Thickness (GT) is determined at 1.5 mm apical to the gingival margin using a caliper (endodontic reamer#20) rounded to the nearest 0.1mm.
Improvement in the Keratinized Tissue Height (KTH)Between the baseline preoperative measurement and follow-up at 3 months and 6 monthsKeratinized Tissue Height (KTH) is measured in millimeters (mm) taken at the mid buccal aspect of the involved teeth from the gingival margin to the muco-gingival junction, by a manual periodontal probe (UNC-15 probe,Hu-Friedy,Chicago,USA).
Measuring Plaque-Index (PI)Between the baseline preoperative measurement and follow-up at 3 months and 6 monthsPlaque-Index (PI) is measured as a percentage of the presence of Plaque on four surfaces of the teeth using a manual periodontal probe.
Reduction in Probing Pocket Depth (PPD)Between the baseline preoperative measurement and follow-up at 3 months and 6 monthsProbing Pocket Depth (PPD) is measured in millimeter (mm) from the gingival margin to the apical extend of the probe.
Reduction Clinical Attachment Level (CAL)Between the baseline preoperative measurement and follow-up at 3 months and 6 monthsClinical Attachment Level (CAL) is measured in millimeter (mm) from the CEJ to the apical extend of the probe.
Reduction in the Recession Width (RW)Between the baseline preoperative measurement and follow-up at 3 months and 6 monthsRecession Width (RW) is measured in millimeter (mm) at the Cement-Enamel Junction (CEJ) using UNC-15 probe.

Countries

Iraq

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026